EUVIMEDEUVIMED entdecken
Crossref

Integrated network pharmacology and serum metabonomics analysis to explore the potential mechanism of Anemarrhena asphodeloides Bunge-Phellodendron chinense Schneid herb pair in the treatment of benign prostatic hyperplasia

Cheng Cheng, Chenglong Xu, Wei Zhou, Lijuan Xue, Shuxuan Wang, Qirui Zhai, Ronghua Dai

Journal of Pharmaceutical and Biomedical Analysis · 2024

DOI: 10.1016/j.jpba.2024.116264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2024. Verfasst von Cheng Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Anemarrhena, Metabolomics, Network Pharmacology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anemarrhena asphodeloides Bunge-Phellodendron chinense Schneid (AAPC) is one of the most widely accepted herb pairs in Chinese medicine prescription for treating benign prostatic hyperplasia (BPH). However, the mechanisms underlying the combination of the two herbs for anti-BPH are still not completely clear. To uncover the potential mechanism of the AAPC herb pair in the treatment of BPH, chemical profiling, network pharmacology, serum metabonomics and experimental validation were integrated. UHPLC-Q-Exactive Orbitrap-MS was performed to characterize the chemical profiling of the herb pair extract, and network pharmacology was employed to forecast the potential effective components, core targets and key signaling pathways. Then, western blot and RT-PCR experiments were conducted to verify the PI3K/Akt/NF-κB signaling pathway predicted by network pharmacology. Finally, the serum differential metabolites and metabolic pathways were analyzed by serum non-targeted metabonomics, and these results were jointly analyzed by MetScape. 51 chemical components of the AAPC herb pair extract were identified, including phellodendrine, magnoflorine, berberine, mangiferin, anemarsaponin BIII, etc. In network pharmacology, the predicted core targets of these components include AKT1, TNF, EGFR, PTGS2, PIK3CA, etc. The KEGG pathway enrichment analysis indicated that PI3K-Akt, Rap1 and MAPK signaling pathways may play a key role in the AAPC herb pair for the treatment of BPH, and the results of animal experiments demonstrated that the herb pair could significantly inhibit the activation and expression of p-PI3K/PI3K, p-Akt/Akt, p-NF-κB/NF-κB in protein and mRNA levels. Furthermore, 31 serum differential metabolites and three main metabolic pathways were obtained by serum non-targeted metabonomics. And the crucial metabolic pathway of arachidonic acid (AA) was obtained by integrated analysis of network pharmacology and metabonomics results. In conclusion, the AAPC herb pair can improve BPH through inhibiting the activation and expression of the PI3K/Akt/NF-κB signaling pathway and AA metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaAnemarrhenaMetabolomicsNetwork PharmacologyPhellodendronDrugs, Chinese HerbalSignal TransductionMaleAnimalsChromatography, High Pressure LiquidProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyNF-kappa BPhosphatidylinositol 3-KinasesPlant Extracts

Stichwörter der Autor:innen

Anemarrhena asphodeloides BungeBenign prostatic hyperplasiaNetwork pharmacologyPhellodendron chinense SchneidSerum metabonomics

Substanzen

Drugs, Chinese HerbalProto-Oncogene Proteins c-aktNF-kappa BPhosphatidylinositol 3-KinasesPlant Extracts

Autor:innen und Institutionen

  • School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China.
  • School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China. Electronic address: ronghuadai@sina.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Cheng, C., Xu, C., Zhou, W., Xue, L., Wang, S., Zhai, Q., & Dai, R. (2024). Integrated network pharmacology and serum metabonomics analysis to explore the potential mechanism of Anemarrhena asphodeloides Bunge-Phellodendron chinense Schneid herb pair in the treatment of benign prostatic hyperplasia. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2024.116264

Vancouver

Cheng C, Xu C, Zhou W, Xue L, Wang S, Zhai Q, et al. Integrated network pharmacology and serum metabonomics analysis to explore the potential mechanism of Anemarrhena asphodeloides Bunge-Phellodendron chinense Schneid herb pair in the treatment of benign prostatic hyperplasia. Journal of Pharmaceutical and Biomedical Analysis. 2024. doi:10.1016/j.jpba.2024.116264

BibTeX
@article{Cheng2024,
  author = {Cheng, Cheng and Xu, Chenglong and Zhou, Wei and Xue, Lijuan and Wang, Shuxuan and Zhai, Qirui and Dai, Ronghua},
  title = {Integrated network pharmacology and serum metabonomics analysis to explore the potential mechanism of Anemarrhena asphodeloides Bunge-Phellodendron chinense Schneid herb pair in the treatment of benign prostatic hyperplasia},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2024},
  doi = {10.1016/j.jpba.2024.116264}
}
Kostenlos starten →